
CALCIPOTRIENE 0.005% / CLOBETASOL PROPIONATE 0.05%
Cs Sincerus Florida. LLC. Adverse reactions zx Active, inactive ed NDC 72934- 4029-3 CALCIPOTRIENE USP 0.005% / CLOBETASOL PROPIONATE USP 0.05%. Solution 60 gm xc.
Cs Sincerus Florida. LLC. Adverse reactions zx Active, inactive ed NDC 72934- 4029-3 CALCIPOTRIENE USP 0.005% / CLOBETASOL PROPIONATE USP 0.05%. Solution 60 gm xc.
C zc Active, inactive axs NDC 72934-2030-2 CALCIPOTRIENE USP 0.005% / DICLOFENAC SODIUM USP 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE USP 2%. Cream 30 gm ds.
Qd Sincerus Florida. LLC. Adverse reactions s Active, inactive sd NDC 72934- 2033-2 CALCIPOTRIENE 0.005% / NIACINAMIDE 4%. Cream 30gm c.
A Sincerus Florida. LLC .Adverse reactions c Active, inactive e NDC 72934-5034-3 CALCIPOTRIENE USP 0.005% / TRIAMCINOLONE ACETONIDE USP 0.1%. Ointment 60gm c.
Calcipotriene foam is indicated for the topical treatment of plaque psoriasis of the scalp and body in adults and pediatric patients 4 years of age and older. Calcipotriene foam is a…
As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2023. All Rights Reserved.